...
首页> 外文期刊>Annals of Thoracic Medicine >Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
【24h】

Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach

机译:非典型表现的严重纤维化性纵隔炎:新型治疗方法的有效控制

获取原文

摘要

Fibrosing mediastinitis (FM), also known as sclerosing mediastinitis, is an uncommon but serious disease involving the mediastinal structures. A high index of suspicion is essential to establish the diagnosis of FM and starting the appropriate therapy for patients. Here, we report a case of a young female who presented with chest symptoms and subsequently underwent different laboratory and radiologic investigations and an excisional biopsy. The findings of these investigations were consistent with the diagnosis of idiopathic FM. Her disease was associated with complete occlusion of three pulmonary veins and the left main pulmonary artery. The patient was treated with initial high-dose steroids followed by maintenance steroid and methotrexate therapy with very good long-term disease control. Clinical response, high-sensitivity C-reactive protein, and erythrocyte sedimentation rate were used to monitor disease activity and response to therapy.
机译:纤维化纵隔炎(FM),也称为硬化性纵隔炎,是一种罕见的但严重的涉及纵隔结构的疾病。高怀疑指数对于确定FM的诊断并为患者开始适当的治疗至关重要。在这里,我们报告了一个年轻女性的病例,该女性表现出胸部症状,随后接受了不同的实验室和放射学检查以及切除活检。这些调查的结果与特发性FM的诊断是一致的。她的疾病与三个肺静脉和左主肺动脉完全闭塞有关。该患者先接受大剂量的类固醇治疗,然后接受维持类固醇和甲氨蝶呤的治疗,长期病情控制良好。临床反应,高敏C反应蛋白和红细胞沉降率用于监测疾病活动和对治疗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号